DYN
Dyne Therapeutics Inc
17.10$
-5.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -42.6% | +62.2% | -63.0% | -100.0% | – | – | – | – | – | – | – | |
| – | +77.1% | +12.5% | +28.5% | -100.0% | +1,029.2% | +158.3% | +55.4% | +207.4% | -26.4% | -8.9% | -8.6% | |
| – | -469.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +158.1% | +309.4% | +168.4% | +17.7% | +47.6% | +33.5% | +41.6% | |
| – | +32.0% | +25.8% | +17.4% | -99.7% | +438.9% | +382.7% | +113.6% | -1.8% | +11.3% | +99.0% | +11.8% | |
| – | – | +25.8% | +17.4% | -97.5% | +188.3% | +324.2% | +155.8% | +14.0% | +40.2% | +42.5% | +36.4% | |
| – | – | -1,100.0% | – | – | – | – | – | – | – | – | – | |
| – | +714.9% | +14.5% | -1.4% | -100.0% | +5,700.0% | +36.6% | +87.4% | +293.1% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -505.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -2,580.0% | – | -106.3% | – | – | – | – | – | – | – | |
| – | +152.1% | -85.6% | +795.3% | -100.5% | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.